Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are quite possibly the most maturely formulated TPD procedures. During this critique, we center on both equally preclinical experiments and medical trials to provide an extensive summary of the protection and clinical performance of PROTACs and MGDs in hematologic malignancies over the https://cyrilc075tzd9.blogunok.com/profile